Anita Bellail
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$2.3MFederal grants as PI3 awards
1Patents grantedLatest Aug 22, 2023
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 19, 2023 | NIH | SBIR Phase II Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer | $980K | HB THERAPEUTICS, INC. |
| Jun 22, 2022 | NIH | SBIR Phase II Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer | $1.0M | HB THERAPEUTICS, INC. |
| Jul 6, 2018 | NIH | SBIR Phase I Development of Small Molecule SUMO1 Inhibitors for Treatment of Glioblastoma | $300K | HB THERAPEUTICS, INC. |
2 patents as inventor
- US 11731985HB THERAPEUTICS, INC.Aug 22, 2023
- US HB THERAPEUTICS, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#856
Awards as PI#822
Patents#155
Companies
- HB THERAPEUTICS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.